Here are the guidelines for the Crohn's & Colitis Foundation’s Career Development Awards:
| Submission Deadlines | |
|---|---|
| Pre-Application | Portal Opens: October 4, 2025 Deadline: December 2, 2025 11:59pm EST |
| Full Proposal (via Invitation) | January 22, 2026 11:59pm EST |
| Applications Review | April – May |
| Decisions Announced | June |
Objective: Career Development Awards are mentored awards intended to facilitate the development of individuals with research potential to prepare for a career of independent basic research investigation in the area of inflammatory bowel disease (IBD).
Stipend & Institutional Allowance: Award salary will match applicants’ institutional salary (salaries may be supplemented by the applicant’s institution), depending on postgraduate year (PGY) level, up to $60,000 per year. Fringe benefits are allowed according to institutional policies, but must not exceed 25% of the salary award (up to $15,000 per year). The Foundation will also provide up to $27,500 to be used for non-salary/fringe expenses such as an MPH degree or equivalent tuition (all degrees must be completed within the three years of this award), statistical support, travel to professional meetings, professional memberships and textbooks. These funds may not be used to supplement awardee’s salary/fringe benefits.
1. Clear Relevance to Inflammatory Bowel Disease (IBD) — Crohn’s or Ulcerative Colitis
The project must directly address IBD (mechanisms, diagnosis, therapy, quality-of-life, etc.).
Proposals unrelated to IBD — or only weakly tied — are unlikely to be competitive.
Takeaway: Make the link to IBD explicit and central from the start.
2. Alignment With the Appropriate Funding Mechanism (Career Stage + Project Type)
CCF offers multiple funding tracks:
Student scholarships
Research Fellowships (postdoc/early-career)
Career Development Awards (early faculty)
Senior Research Awards (established investigators)
Clinical Investigator-Initiated Awards (clinical researchers)
Specialized mechanisms (e.g. “Pioneers”, “IBD Ventures”) including translational/product-development grants.
Predictor: Select the grant track that matches your career stage and the maturity of your project. Reviewers expect appropriate scope, scale, and ambition.
3. Innovation + Addressing Unmet Needs in IBD
CCF values proposals that tackle pressing gaps — for example:
Novel therapeutic targets (beyond current biologics)
Pathways for patients unresponsive to existing therapies
Biomarkers for prognosis, disease stratification, or response prediction
Approaches for barrier repair, mucosal healing, microbiome modulation, fibrosis prevention
Digital health, patient-reported outcomes, disease monitoring tools
These match their stated long-term goal: cures and improved quality of life.
4. Strong, Feasible Experimental or Clinical Design with Clear Aims
Competitive proposals generally have:
2–3 focused, hypothesis-driven aims
Realistic timeline (1–3 years depending on grant)
Clearly defined milestones & deliverables
Appropriate methods: preclinical models, human samples/cohorts, clinical endpoints
Clear plan for data analysis and interpretation
Overly broad, speculative, or poorly outlined proposals tend to fare poorly.
5. Solid Preliminary Data (Especially for Fellowships / Senior Awards / Translational Grants)
Although early-stage funding exists, projects with supporting pilot data (in vitro, in vivo, or clinical cohorts) stand out — demonstrates feasibility and reduces risk. This is especially critical for translational or product-development applications.
6. Access to Appropriate IBD Models, Cohorts, or Clinical Resources
Strong proposals typically leverage:
Preclinical models relevant to IBD (animal models of colitis, organoids, epithelial barrier assays)
Human patient samples (biopsy, blood, stool), or ability to recruit IBD patients
Clinical or translational infrastructure for biomarker studies or small interventional trials
Access to such resources increases confidence in deliverability.
7. Investigator Expertise, Commitment, and (for Early Awards) Mentorship / Training Environment
For early-career applicants (Fellowship / Career Development), reviewers look for:
Strong mentorship plan
Institutional support (protected time, core resources)
Clear career trajectory toward independent IBD research
For more senior applicants: consistent track record, prior publications, and capacity to lead high-impact IBD research.
8. Potential for Real-World Impact (Therapy, Diagnostics, Patient Quality of Life)
CCF prioritizes work that can translate into:
New or improved therapies
Predictive or diagnostic biomarkers
Approaches to reduce treatment failure or toxicity
Improved patient monitoring, quality of life, or disease management
Demonstrating a pathway from research to patient benefit significantly strengthens proposals.
9. Clear, Well-Written, Strategically Sound Proposals with Transparent Use of Funds
Proposals that are easy to read, logically structured, and transparent about budgets tend to score higher. Because CCF funds many small-to-medium grants, clarity and cost-effectiveness matter.
10. For Product- or Device-Focused Proposals: Embrace Translational & Entrepreneurial Vision (IBD Ventures)
CCF also supports product development (drugs, devices, diagnostics, digital tools) under IBD Ventures — funding up to US $500,000 + advising/accelerator support.
Working on novel diagnostics, safer therapies, microbiome-based treatments, digital health solutions, or device-based IBD management can be competitive under this track — especially if you blend robust science with clear commercialization potential.
Make IBD relevance unambiguous from title thru aims
Target the correct grant type — don’t overreach or under-scope
Articulate a clear unmet need or knowledge gap in IBD
Use focused, feasible aims with realistic timelines
Provide pilot data or strong rationale for feasibility
Show you have resources, patient access, or model systems to carry out the work
Emphasize translational potential or patient impact
For early-career grants — ensure strong mentorship and protected research time
If proposing a therapy or product — include path to development, regulatory or translational plan, and cost-effectiveness arguments
Write clearly, concisely — reviewers may read many proposals
The Foundation is sensitive to personal matters that impact career trajectories. Applicants who have taken leave from their career (e.g., parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues), or have been impacted by the COVID-19 pandemic in a way that puts them outside of the eligibility time frame, should feel free to reach out to Foundation staff ahead of their application submission. We aim to be flexible and adjust these time frames if necessary and appropriate. This can be captured in the applicant's cover letter.*
Individuals who are already well established in the field of IBD research are not considered eligible for this award. Applicants should identify a senior investigator to act as a mentor to facilitate the transition to independence. At the time of application, applicants must be employed by an institution (public non-profit, private non-profit, or government) engaged in health care and/or health related research within the United States. Research is not restricted by citizenship; however, proof of legal work status is required. Applicants must hold an MD and/or PhD (or equivalent degree). Candidates holding MD degrees must have five years of experience after receiving their terminal degree—two years of which must be documented research experience relevant to IBD. Applicants holding PhDs must have at least two years of documented post-doctoral research relevant to IBD. Generally, candidates should not be in excess of ten years beyond the attainment of their doctoral degree.
Proposal Eligibility: Proposal MUST be relevant to IBD (Crohn's disease and/or ulcerative colitis) and must contain a career development plan detailing a training plan, mentorship plan, and describe how receiving this award will facilitate the transition to independence. Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and Training Award is not permitted.
Sponsor Institute/Organizations: Crohn's & Colitis Foundation of America
Sponsor Type: Corporate/Non-Profit
Address: 733 THIRD AVENUE, SUITE 510, NEW YORK, NY 10017
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 22, 2026
Jan 22, 2026
$102,500
Affiliation: Crohn's & Colitis Foundation of America
Address: 733 THIRD AVENUE, SUITE 510, NEW YORK, NY 10017
Website URL: https://www.crohnscolitisfoundation.org/research/grants-fellowships/career-development-awards
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.